| 24.99 0.01 (0.04%) | 07-24 16:03 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 29.19 | 1-year : | 34.1 |
| Resists | First : | 25 | Second : | 29.19 |
| Pivot price | 24.95  |
|||
| Supports | First : | 24.66 | Second : | 24.45 |
| MAs | MA(5) : | 24.98 |
MA(20) : | 24.93 |
| MA(100) : | 21.6 |
MA(250) : | 15.85 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 89.6 |
D(3) : | 93.2 |
| RSI | RSI(14): 62.1 |
|||
| 52-week | High : | 25.48 | Low : | 9.3 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ AVNS ] has closed below upper band by 16.1%. Bollinger Bands are 96.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 56 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 25.02 - 25.14 | 25.14 - 25.25 |
| Low: | 24.68 - 24.83 | 24.83 - 24.95 |
| Close: | 24.78 - 25 | 25 - 25.19 |
Avanos Medical, Inc. is a pioneering medical technology enterprise dedicated to furnishing device solutions across a broad international footprint, encompassing North America, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America. Its comprehensive product array targets two primary areas: chronic care and non-opioid pain management. Within chronic care, the company provides digestive health offerings such as Mic-Key enteral feeding tubes, Corpak patient feeding systems, and NeoMed solutions tailored for neonatal and pediatric patients. Its respiratory health segment includes closed airway suction systems and other airway management devices, marketed under prominent brands like Ballard, Microcuff, and Endoclear. For non-opioid pain relief, Avanos offers acute pain solutions, including On-Q and ambIT surgical pain pumps, along with Game Ready cold and compression therapy systems. It also features interventional pain solutions, providing minimally invasive therapies like Coolief for long-term pain alleviation. The company facilitates product access by selling directly to hospitals, various healthcare providers, and end-user facilities, in addition to utilizing third-party wholesale distributors. Originally incorporated in 2014 and known as Halyard Health, Inc., the company officially adopted the name Avanos Medical, Inc. in June 2018 and maintains its headquarters in Alpharetta, Georgia.
Wed, 22 Jul 2026
Avanos cash deal expected to close by July 27 after ~99.75% approval - Stock Titan
Wed, 22 Jul 2026
Avanos Medical, Inc. Stockholders Approve Acquisition by American Industrial Partners - PR Newswire
Thu, 02 Jul 2026
Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger - PR Newswire
Thu, 02 Jul 2026
Avanos receives regulatory approvals, merger expected to close by July 27 pending shareholder vote - TradingView
Thu, 04 Jun 2026
A Look At Avanos Medical (AVNS) Valuation After Recent 3 Month Share Price Surge - Yahoo Finance
Wed, 15 Apr 2026
Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNS - FinancialContent
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 47 (M) |
| Shares Float | 46 (M) |
| Held by Insiders | 3.2 (%) |
| Held by Institutions | 93.1 (%) |
| Shares Short | 1,750 (K) |
| Shares Short P.Month | 1,710 (K) |
| EPS | -1.61 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 16.76 |
| Profit Margin | -10.4 % |
| Operating Margin | 5.3 % |
| Return on Assets (ttm) | 0.9 % |
| Return on Equity (ttm) | -9.2 % |
| Qtrly Rev. Growth | 8.8 % |
| Gross Profit (p.s.) | 7.64 |
| Sales Per Share | 15.28 |
| EBITDA (p.s.) | 1.19 |
| Qtrly Earnings Growth | -21.8 % |
| Operating Cash Flow | 37 (M) |
| Levered Free Cash Flow | 17 (M) |
| PE Ratio | -15.62 |
| PEG Ratio | 0 |
| Price to Book value | 1.49 |
| Price to Sales | 1.63 |
| Price to Cash Flow | 31.9 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|